| Title： | Dynamic Clinical Practice Guidelines for the Perioperative Period of Myocardial Infarction PCI with Traditional Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis |
| Edition： | Original |
| Classification： | Traditional Chinese Medicine guideline |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians specializing in the treatment of myocardial infarction, including those practicing traditional Chinese medicine (TCM), Western medicine, and integrated Chinese-Western medicine approaches. |
| Evidence classification method： | Grade Evidence Rating |
| Development unit： | dongzhimen hospital of beijing university of chinese medicine、zhongnan hospital of wuhan university et al |
| Registration time: | 2024-04-29 |
| Registration number： | PREPARE-2024CN596 |
| Purpose of the guideline: | While the effectiveness and safety of PCI are widely recognized, issues such as no-reflow and slow-flow phenomenon, ischemia-reperfusion injury, perioperative myocardial damage, in-stent restenosis, and in-stent thrombosis persist, which may impact the long-term survival quality and treatment outcomes of patients. Therefore, seeking additional therapeutic measures is of paramount importance to improve the treatment efficacy of PCI and the quality of life of patients. In recent years, high-quality evidence from evidence-based medicine has demonstrated the advantages of traditional Chinese medicine (TCM) in the treatment of myocardial infarction (MI). This continuous stream of evidence-based medicine provides a solid foundation for the formulation of guidelines. Given the increasingly urgent demand for TCM in the perioperative period of MI PCI and the complementary advantages of TCM and Western medicine in different treatment stages, it is imperative to develop dynamic clinical practice guidelines for the perioperative period of MI PCI with traditional Chinese medicine for promoting blood circulation and removing blood stasis. |
